Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred


SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4315
See all formats and pricing

 


 
 

Select Volume and Issue
Loading journal volume and issue information...

Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS

M. G. Donner / U. Warskulat / N. Saha / D. Häussinger

Citation Information: Biological Chemistry. Volume 385, Issue 3-4, Pages 331–339, ISSN (Print) 1431-6730, DOI: 10.1515/BC.2004.029, June 2005

Publication History

Published Online:
2005-06-01

Abstract

Lipopolysaccharide (LPS) induces hepatocellular downregulation and endocytic retrieval of multidrug resistance protein 2 (Mrp2, Abcc2). Basolateral Mrp isoforms may compensate for the intracellular metabolic changes in cholestasis. Therefore, the effect of LPS on the zonal localization of Mrp2 and Mrp3 and the expression of Mrp3, Mrp4, Mrp5, and Mrp6 mRNA were investigated in rat liver. In normal rat liver Mrp3 was found in pericentral hepatocytes also expressing glutamine synthetase. In LPS-treated rat liver the decrease in Mrp2 protein was most pronounced in pericentral hepatocytes, with only minor down-regulation in periportal hepatocytes. Conversely, induction of Mrp3 was found in pericentral hepatocytes with a low expression of Mrp2. Furthermore, we found a strong induction of Mrp5 mRNA. Likewise, Mrp6 mRNA was upregulated, however Mrp6 protein expression was not significantly altered. It is concluded that Mrp3 is inversely regulated to Mrp2 in a zonal pattern and may compensate for the LPSinduced loss of Mrp2 in the perivenous area. Induction of pericentral Mrp3 and upregulation of Mrp5 mRNA may play an important role in the hepatocellular clearance of cholephilic substances and cyclic nucleotides accumulating after LPS treatment.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Marc Jenniskens, Lies Langouche, Yoo-Mee Vanwijngaerden, Dieter Mesotten, and Greet Van den Berghe
Intensive Care Medicine, 2015
[2]
Xinsheng Gu and Jose E. Manautou
Drug Metabolism Reviews, 2010, Volume 42, Number 3, Page 482
[3]
Andreas Geier, Martin Wagner, Christoph G. Dietrich, and Michael Trauner
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007, Volume 1773, Number 3, Page 283
[4]
Clifford M. Babbey, Jennifer C. Ryan, Erin M. Gill, Marwan S. Ghabril, Courtney R. Burch, April Paulman, and Kenneth W. Dunn
IntraVital, 2012, Volume 1, Number 1, Page 44
[6]
María Laura Ruiz, Juan Pablo Rigalli, Agostina Arias, Silvina Stella Maris Villanueva, Claudia Banchio, Mary Vore, Aldo Domingo Mottino, and Viviana Alicia Catania
Biochemical Pharmacology, 2013, Volume 86, Number 3, Page 401
[7]
Eva Ramboer, Tamara Vanhaecke, Vera Rogiers, and Mathieu Vinken
Drug Metabolism Reviews, 2013, Volume 45, Number 2, Page 196
[8]
Mie Rostved Rasmussen, Mette Sommerlund, and Søren Kragh Moestrup
Expert Review of Endocrinology & Metabolism, 2013, Volume 8, Number 1, Page 37
[9]
Jin Chai, Yu He, Shi-Ying Cai, Zhongyong Jiang, Huaizhi Wang, Qiong Li, Lei Chen, Zhihong Peng, Xiaochong He, Xiaoping Wu, Tianli Xiao, Rongquan Wang, James L. Boyer, and Wensheng Chen
Hepatology, 2012, Volume 55, Number 5, Page 1485
[10]
Peter Recknagel, Ralf A. Claus, Ute Neugebauer, Michael Bauer, and Falk A. Gonnert
Journal of Biophotonics, 2012, Volume 5, Number 7, Page 571
[11]
Emmanuel A. Ho and Micheline Piquette-Miller
Biochemical and Biophysical Research Communications, 2007, Volume 353, Number 3, Page 679
[12]
Maciej J. Zamek-Gliszczynski, Keith A. Hoffmaster, Ken-ichi Nezasa, Melanie N. Tallman, and Kim L.R. Brouwer
European Journal of Pharmaceutical Sciences, 2006, Volume 27, Number 5, Page 447
[13]
Alison E. Aitken, Terrilyn A. Richardson, and Edward T. Morgan
Annual Review of Pharmacology and Toxicology, 2006, Volume 46, Number 1, Page 123
[14]
Joost Wauters, Dieter Mesotten, Kenny Van Zwam, Jos van Pelt, Steven Thiessen, Anne-Sophie Dieudonné, Sara Vander Borght, Greet Van den Berghe, and Alexander Wilmer
Shock, 2010, Volume 34, Number 5, Page 508
[15]
M Arrese and S J Karpen
Clinical Pharmacology & Therapeutics, 2010, Volume 87, Number 4, Page 473
[16]
Eva Brcakova, Leos Fuksa, Jolana Cermanova, Gabriela Kolouchova, Milos Hroch, Petra Hirsova, Jirina Martinkova, Frantisek Staud, and Stanislav Micuda
Biological & Pharmaceutical Bulletin, 2009, Volume 32, Number 12, Page 1978
[17]
J. M. Maher, L. M. Aleksunes, M. Z. Dieter, Y. Tanaka, J. M. Peters, J. E. Manautou, and C. D. Klaassen
Toxicological Sciences, 2008, Volume 106, Number 2, Page 319
[18]
Stanislav Micuda, Leos Fuksa, Eva Brcakova, Jan Osterreicher, Jolana Cermanova, Norbert Cibicek, Jaroslav Mokry, Frantisek Staud, and Jirina Martinkova
Journal of Gastroenterology and Hepatology, 2008, Volume 23, Number 7pt2, Page e225
[19]
K. Sandy Pang, Michael Weiss, and Panos Macheras
The AAPS Journal, 2007, Volume 9, Number 2, Page E268
[20]
Hui Cai and Lucian V. Del Priore
Current Eye Research, 2006, Volume 31, Number 2, Page 181
[21]
Verena Keitel, Martin Burdelski, Ulrich Warskulat, Thomas K�hlkamp, Dietrich Keppler, Dieter H�ussinger, and Ralf Kubitz
Hepatology, 2005, Volume 41, Number 5, Page 1160

Comments (0)

Please log in or register to comment.